Provider
QP41-22 MHCP Pharmacy Benefit Exclusion for Opdualag™ and paclitaxel protein-bound particles
Program effective Date: May 25, 2022
Documents & Forms Results
Displaying 1801 - 1810 of 3629 results
Provider
QP42-22 Reminder: Self-Administered Drug Coverage for Medicare Members
Program effective Date: May 25, 2022
Provider
QP43-22 Reminder: Medical Drug Coding for Botulinum Toxins
Program effective Date: May 25, 2022
Provider
QP44-22 Improved Provider Webpage
Program effective Date: May 25, 2022
Provider
QP95-21 Update for New to Market Medical Drugs: triamcinolone acetonide injectable suspension (Xipere) and vutrisiran
Program effective Date: Dec 08, 2021
Provider
QP96-21 Processing Change for HCPCS Code A9279
Program effective Date: Dec 08, 2021
Provider
QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™
Program effective Date: Dec 08, 2021
Provider
QP98-21 Commercial Pharmacy Benefit Exclusion for Nulojix® and Susvimo™
Program effective Date: Dec 08, 2021